Patent rewards: Applications in type 2 diabetes and diabetic wound healing.
- US 9,655,891 B1 USE OF ISOQUINOLINE
DERIVATIVES FOR DIABETIC WOUND HEALING
- US 9,707,222 B2 ISOQUINOLINEALKALOID DERIVATIVE FOR ACTIVATING AMP-DEPENDENT PROTEINKINASE
1. GYT002 effectively decreases hepatic glucose for
type II DM through low dose. Fitting the potential hypoglycemic agent invention trend for type II DM.。
2. GYT005, derived from GYT002, is highly efficiency for wound-healing on diabetes.
The market value of GYT005 for wound-healing on
diabetes is estimated for US$10
billion per year.
The revenues of GYT002 and GYT005 are both estimated
to be at least 4 billion USD in new drugs market per year.
Investments and related disease association are welcomed.
For more informationvia: email@example.com